Hemozoin as a novel adjuvant for inactivated whole virion influenza vaccine.
暂无分享,去创建一个
C. Coban | K. Ishii | M. Kiso | Y. Kawaoka | M. Hatta | Subash Das | M. Ozawa | Ryuta Uraki | K. Iwatsuki-Horimoto | R. Uraki | Maki Kiso
[1] C. Coban,et al. Hemozoin is a potent adjuvant for hemagglutinin split vaccine without pyrogenicity in ferrets. , 2014, Vaccine.
[2] S. Reed,et al. Key roles of adjuvants in modern vaccines , 2013, Nature Medicine.
[3] M. Kiso,et al. A Novel Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice from Pandemic H1N1 and Highly Pathogenic H5N1 Virus Challenges , 2013, Journal of Virology.
[4] K. Ishii,et al. Adjuvants in influenza vaccines. , 2012, Vaccine.
[5] Y. Kawaoka,et al. Nanoemulsion W805EC improves immune responses upon intranasal delivery of an inactivated pandemic H1N1 influenza vaccine. , 2012, Vaccine.
[6] Tadaki Suzuki,et al. Mucosal IgA responses in influenza virus infections; thoughts for vaccine design. , 2012, Vaccine.
[7] M. Tashiro,et al. Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccine , 2012, Journal of medical virology.
[8] Ryo Takano,et al. Mutations in PA, NP, and HA of a pandemic (H1N1) 2009 influenza virus contribute to its adaptation to mice. , 2011, Virus research.
[9] G. Neumann,et al. The first influenza pandemic of the new millennium , 2011, Influenza and other respiratory viruses.
[10] I. Srivastava,et al. Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens , 2011, Expert review of vaccines.
[11] A. Fauci,et al. Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine , 2010, Nature Medicine.
[12] M. Olivier,et al. Innate inflammatory response to the malarial pigment hemozoin. , 2010, Microbes and infection.
[13] Jin Hyun Kim,et al. Biological and Structural Characterization of a Host-Adapting Amino Acid in Influenza Virus , 2010, PLoS pathogens.
[14] Sanjeev Kumar,et al. Protein–DNA Complex Is the Exclusive Malaria Parasite Component That Activates Dendritic Cells and Triggers Innate Immune Responses , 2010, The Journal of Immunology.
[15] C. Coban,et al. Immunogenicity of Whole-parasite Vaccines against Plasmodium Falciparum Involves Malarial Hemozoin and Host Tlr9 , 2022 .
[16] I. Stephenson,et al. Influenza vaccines for the future , 2009 .
[17] W. Cao,et al. Increased sensitivity for detecting avian influenza-specific antibodies by a modified hemagglutination inhibition assay using horse erythrocytes. , 2008, Journal of virological methods.
[18] G. Kayali,et al. Testing human sera for antibodies against avian influenza viruses: horse RBC hemagglutination inhibition vs. microneutralization assays. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[19] A. Osterhaus,et al. Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development. , 2007, Current opinion in biotechnology.
[20] B. Monks,et al. Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9 , 2007, Proceedings of the National Academy of Sciences.
[21] C. Coban,et al. Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin , 2005, The Journal of experimental medicine.
[22] N. Petrovsky,et al. Vaccine adjuvants: Current state and future trends , 2004, Immunology and cell biology.
[23] W. Glezen. Cold-adapted, live attenuated influenza vaccine , 2004, Expert review of vaccines.
[24] R. Cox,et al. Influenza Virus: Immunity and Vaccination Strategies. Comparison of the Immune Response to Inactivated and Live, Attenuated Influenza Vaccines , 2004, Scandinavian journal of immunology.
[25] J. A. Misplon,et al. Heterosubtypic Immunity to Influenza A Virus in Mice Lacking IgA, All Ig, NKT Cells, or γδ T Cells1 , 2001, The Journal of Immunology.
[26] T. Tumpey,et al. Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection , 2001, Journal of Virology.
[27] J. A. Misplon,et al. Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells. , 2001, Journal of immunology.
[28] P. Arese,et al. Malarial pigment (haemozoin): a very active 'inert' substance. , 1997, Annals of tropical medicine and parasitology.
[29] D. Sullivan,et al. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. , 1997, Annual review of microbiology.
[30] R. Jonsson,et al. Parenteral influenza vaccination induces a rapid systemic and local immune response. , 1995, The Journal of infectious diseases.
[31] J. Oxford,et al. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. , 1994, Vaccine.
[32] B. Murphy,et al. Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus , 1986, Journal of clinical microbiology.
[33] R. Webster,et al. Biological activity of monoclonal antibodies to operationally defined antigenic regions on the hemagglutinin molecule of A/Seal/Massachusetts/1/80 (H7N7) influenza virus. , 1982, Virology.